Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. EBS has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
EBS stock price ended at $6.73 on Monday, after rising1.36%
The Emergent BioSolutions Inc stock price increased by 1.36% on the last trading day (19 May 2025), rising from 6.45 to 6.73. Throughout the last trading session, the stock experienced a fluctuation of 6.37% , ranging from a day low of $6.36 to a day high of 6.765. The price has declined in 5 of the last 10 days, resulting in a total change of 35.96% during this period. On the last day, trading volume decrease by -1.62M shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 1.34M shares were traded, amounting to approximately 8.89M.
EBS Technical Signals
EBS(Emergent BioSolutions Inc Corp) has 7 buy signals and 2 sell signals now. The current trend is downtrend starting from 2025-04-25. The total price change during this trend is +20.95%. Recently, the price has increased significantly with an increase in volume, indicating a strong bullish signal. The average turnover of EBS over the last 5 trading days is 9.20M. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
EBS Moving Average Analysis
Emergent BioSolutions Inc's overall moving average trend leans more bullish as of Tuesday, May 20, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $6.899153333333334, and $7.659333333333334. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $4.439513333333334, and $3.679333333333334. A break-down below any of these levels will issue sell signals.
EBS Short Selling Analysis
The short sale ratio of Emergent BioSolutions Inc(EBS) as of 12 May 2025 is 6.55%, dropping from last trading day. With decreasing price from 5.65 to 5.84. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Sell
2
Buy
7
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
7 Bullish Signals
7 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
0.795
Bullish
Momentum (10 days)
MOM_10 > 0
1.5
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.206
Bullish
Closing price
close > fibonacci_R1
6.64
Bullish
Moving Average
Price crosses above 5-day SMA
--
Bullish
Moving Average
Price crosses above 60-day SMA
--
Bullish
Moving Average
10-day SMA crosses above 60-day SMA
--
Bullish
2 Bearish Signals
2 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 > 100
176.701
Bearish
Williams %R (14 days)
WILLR_14 > -20
-3.015
Bearish
EBS Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Emergent BioSolutions Inc(EBS), our algorithm predicts EBS's 1-month price at $6.67, with an 0.38%upwardshift. Using a similarity score up to 95.01%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Emergent BioSolutions Inc (EBS.N) stock, as of Sunday, May 18, 2025 , forecasts a 0.38% change over the next month, based on its high correlation with ATO.N stock patterns. The similarity between their price movements over the analyzed periods is 95.01%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
EBS
No Data
ATO
Up: 0.38%Similarity: 95.01%
Name
Similarity
Up/Down
ATO.N
95.01%
+0.38%
EGHT.O
93.35%
-2.12%
NFE.O
93.29%
-7.98%
HURA.O
93.20%
-10.20%
NOW.N
93.18%
+1.28%
TFC.N
93.08%
+1.11%
KAVL.O
93.06%
+33.00%
OLB.O
92.62%
0.00%
CACI.N
92.56%
+1.84%
ULBI.O
92.53%
+3.05%
EBS Seasonality Analysis
Based on EBS's historical stock price data across all years, the probability of a positive return in May is63.64%, suggesting it maybe an ideal month to invest in EBS. In contrast,Januaryoffers the highest probability of positive returns at72.73%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Emergent BioSolutions Inc (EBS.N) stock in January has the highest probability of a positive return (72.73%), while March has the lowest probability (18.18%).
Performance Seasonality
The chart shows Emergent BioSolutions Inc. (EBS)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Emergent BioSolutions Inc (EBS.N) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. EBS has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Emergent BioSolutions Inc (EBS.N) stock in a year?
The radar chart shows that buying Emergent BioSolutions Inc (EBS.N) stock in January has the highest probability of a positive return (72.73%), while March has the lowest probability (18.18%).
How has Emergent BioSolutions Inc. (EBS)'s stock price performed over the past three years?
EBS's stock price fell by -80.03% in 2023,increased by 269.11% in 2024, and went down by 34.47% in 2025.
Is EBS a buy based on overall technical signals summary?
EBS has 7 buy signals and 2 sell signals now. Overall the technical rating for EBS is Strong buy . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of EBS.
What is the trend of Emergent BioSolutions Inc (EBS)'s moving average?
Emergent BioSolutions Inc's overall moving average trend leans more bullish as of May 20 2025, with 2 negative signals and 2 positive signal.
What is price prediction for EBS stock next month?
The price prediction chart for Emergent BioSolutions Inc (EBS.N) stock, as of May 18 2025, forecasts a 0.38% change over the next month, based on its high correlation with ATO stock patterns. The similarity between their price movements over the analyzed periods is 95.01%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for EBS Stock?
EBS stock is predicted to reach **$7.50 by year-end 2025**, driven by strong financial results and new contracts. The stock currently shows bullish momentum with a 6% increase after the Ontario Ministry of Health agreement. Technical indicators suggest upward potential, supported by improving fundamentals.
What is price prediction 2030 for EBS Stock?
### **Price Prediction for EBS Stock by 2030**
Based on current trends and analysis, Emergent BioSolutions (EBS) is projected to reach **$15.00 by 2030**. This prediction is supported by the company's strong turnaround progress, including a recent $65 million contract for Narcan nasal spray and improved financial metrics such as net income of $68 million. Analysts maintain an average 12-month target of $15.00, reflecting confidence in the company's growth potential.